Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to -$17.2 million.

  • Phibro Animal Health's Cash from Investing Activities rose 9340.28% to -$17.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$63.5 million, marking a year-over-year increase of 7660.77%. This contributed to the annual value of -$288.7 million for FY2025, which is 49901.23% down from last year.
  • Per Phibro Animal Health's latest filing, its Cash from Investing Activities stood at -$17.2 million for Q4 2025, which was up 9340.28% from -$21.0 million recorded in Q3 2025.
  • In the past 5 years, Phibro Animal Health's Cash from Investing Activities registered a high of $17.6 million during Q4 2021, and its lowest value of -$260.5 million during Q4 2024.
  • Its 5-year average for Cash from Investing Activities is -$23.5 million, with a median of -$10.1 million in 2022.
  • In the last 5 years, Phibro Animal Health's Cash from Investing Activities skyrocketed by 33043.02% in 2021 and then tumbled by 171513.27% in 2025.
  • Over the past 5 years, Phibro Animal Health's Cash from Investing Activities (Quarter) stood at $17.6 million in 2021, then plummeted by 155.84% to -$9.8 million in 2022, then tumbled by 153.43% to -$24.9 million in 2023, then plummeted by 947.72% to -$260.5 million in 2024, then soared by 93.4% to -$17.2 million in 2025.
  • Its Cash from Investing Activities was -$17.2 million in Q4 2025, compared to -$21.0 million in Q3 2025 and -$7.0 million in Q2 2025.